1
|
Nelson CM and Bissell MJ: Modeling dynamic
reciprocity: engineering three-dimensional culture models of breast
architecture, function, and neoplastic transformation. Semin Cancer
Biol. 15:342–352. 2005.
|
2
|
Ghajar CM and Bissell MJ: Extracellular
matrix control of mammary gland morphogenesis and tumorigenesis:
insights from imaging. Histochem Cell Biol. 130:1105–1118.
2008.
|
3
|
Lin CQ and Bissell MJ: Multi-faceted
regulation of cell differentiation by extracellular matrix. FASEB
J. 7:737–743. 1993.
|
4
|
Vuorio E and de Crombrugghe B: The family
of collagen genes. Annu Rev Biochem. 59:837–872. 1990.
|
5
|
Cutroneo KR: How is Type I procollagen
synthesis regulated at the gene level during tissue fibrosis. J
Cell Biochem. 90:1–5. 2003.
|
6
|
Sodek KL, Brown TJ and Ringuette MJ:
Collagen I but not Matrigel matrices provide an MMP-dependent
barrier to ovarian cancer cell penetration. BMC Cancer.
8:2232008.
|
7
|
Cauwe B, Van den Steen PE and Opdenakker
G: The biochemical, biological, and pathological kaleidoscope of
cell surface substrates processed by matrix metalloproteinases.
Crit Rev Biochem Mol Biol. 42:113–185. 2007.
|
8
|
Maquoi E, Assent D, Detilleux J, Pequeux
C, Foidart JM and Noël A: MT1-MMP protects breast carcinoma cells
against type I collagen-induced apoptosis. Oncogene. 31:480–493.
2012.
|
9
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997.
|
10
|
Björklund M and Koivunen E:
Gelatinase-mediated migration and invasion of cancer cells. Biochim
Biophys Acta. 1755:37–69. 2005.
|
11
|
Nakajima M, Welch DR, Wynn DM, Tsuruo T
and Nicolson GL: Serum and plasma M(r) 92,000 progelatinase levels
correlate with spontaneous metastasis of rat 13762NF mammary
adenocarcinoma. Cancer Res. 53:5802–5807. 1993.
|
12
|
Duffy MJ, Maguire TM, Hill A, McDermott E
and O’Higgins N: Metalloproteinases: role in breast carcinogenesis,
invasion and metastasis. Breast Cancer Res. 2:252–257. 2000.
|
13
|
Kim S, Choi JH, Lim HI, et al: EGF-induced
MMP-9 expression is mediated by the JAK3/ERK pathway, but not by
the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line. Cell
Signal. 21:892–898. 2009.
|
14
|
Shekhar MP, Werdell J, Santner SJ, Pauley
RJ and Tait L: Breast stroma plays a dominant regulatory role in
breast epithelial growth and differentiation: implications for
tumor development and progression. Cancer Res. 61:1320–1326.
2001.
|
15
|
Mao Y, Keller ET, Garfield DH, Shen K and
Wang J: Stromal cells in tumor microenvironment and breast cancer.
Cancer Metastasis Rev. 32:303–315. 2013.
|
16
|
Angelucci C, Maulucci G, Lama G, et al:
Epithelial-stromal interactions in human breast cancer: effects on
adhesion, plasma membrane fluidity and migration speed and
directness. PLoS One. 7:e508042012.
|
17
|
Kim S, Kim Y, Lee Y and Chung JH: Ceramide
accelerates ultraviolet-induced MMP-1 expression through
JAK1/STAT-1 pathway in cultured human dermal fibroblasts. J Lipid
Res. 49:2571–2581. 2008.
|
18
|
Hynes RO: The extracellular matrix: not
just pretty fibrils. Science. 326:1216–1219. 2009.
|
19
|
Henriet P, Zhong ZD, Brooks PC, Weinberg
KI and DeClerck YA: Contact with fibrillar collagen inhibits
melanoma cell proliferation by up-regulating p27KIP1. Proc Natl
Acad Sci USA. 97:10026–10031. 2000.
|
20
|
Barkan D, El Touny LH, Michalowski AM, et
al: Metastatic growth from dormant cells induced by a
col-I-enriched fibrotic environment. Cancer Res. 70:5706–5716.
2010.
|
21
|
Bhowmick NA, Neilson EG and Moses HL:
Stromal fibroblasts in cancer initiation and progression. Nature.
432:332–337. 2004.
|
22
|
Proia DA and Kuperwasser C: Stroma: tumor
agonist or antagonist. Cell Cycle. 4:1022–1025. 2005.
|
23
|
Kojima Y, Acar A, Eaton EN, et al:
Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1)
signaling drives the evolution of tumor-promoting mammary stromal
myofibroblasts. Proc Natl Acad Sci USA. 107:20009–20014. 2010.
|
24
|
Orimo A, Gupta PB, Sgroi DC, et al:
Stromal fibroblasts present in invasive human breast carcinomas
promote tumor growth and angiogenesis through elevated SDF-1/CXCL12
secretion. Cell. 121:335–348. 2005.
|
25
|
Crowe DL, Tsang KJ and Shemirani B: Jun
N-terminal kinase 1 mediates transcriptional induction of matrix
metalloproteinase 9 expression. Neoplasia. 3:27–32. 2001.
|
26
|
Choi JY, Jang YS, Min SY and Song JY:
Overexpression of MMP-9 and HIF-1α in breast cancer cells under
hypoxic conditions. J Breast Cancer. 14:88–95. 2011.
|
27
|
Kim BG, An HJ, Kang S, et al:
Laminin-332-rich tumor microenvironment for tumor invasion in the
interface zone of breast cancer. Am J Pathol. 178:373–381.
2011.
|
28
|
Ma XJ, Dahiya S, Richardson E, Erlander M
and Sgroi DC: Gene expression profiling of the tumor
microenvironment during breast cancer progression. Breast Cancer
Res. 11:R72009.
|
29
|
Provenzano PP, Inman DR, Eliceiri KW, et
al: Collagen density promotes mammary tumor initiation and
progression. BMC Med. 6:112008.
|
30
|
Ramaswamy S, Ross KN, Lander ES and Golub
TR: A molecular signature of metastasis in primary solid tumors.
Nat Genet. 33:49–54. 2003.
|
31
|
Park CC, Rembert J, Chew K, Moore D and
Kerlikowske K: High mammographic breast density is independent
predictor of local but not distant recurrence after lumpectomy and
radiotherapy for invasive breast cancer. Int J Radiat Oncol Biol
Phys. 73:75–79. 2009.
|